PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers, predicting patient outcomes with over 90% accuracy. With strong backing from leading pharma clients, their innovative SpaceIQ platform accelerates drug discovery, reduces clinical trial risks, and is poised to impact the lives of over 25 million cancer patients worldwide.
